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Background: Implementation of interventions in real-life settings requires a comprehensive evaluation approach.
The aim of this article is to describe the evaluation design of the SLIMMER diabetes prevention intervention in a
Dutch real-life setting.
Methods/Design: The SLIMMER study is a randomised, controlled intervention study including subjects aged 40
through 70 years with impaired fasting glucose or high risk of diabetes. The 10-month SLIMMER intervention involves a
dietary and physical activity intervention, including case management and a maintenance programme. The control group
receives usual health care and written information about a healthy lifestyle. A logic model of change is composed to link
intervention activities with intervention outcomes in a logical order. Primary outcome is fasting insulin. Measurements are
performed at baseline and after 12 and 18 months and cover quality of life, cardio-metabolic risk factors (e.g. glucose
tolerance, serum lipids, body fatness, and blood pressure), eating and physical activity behaviour, and behavioural
determinants. A process evaluation gives insight in how the intervention was delivered and received by participants and
health care professionals. The economic evaluation consists of a cost-effectiveness analysis and a cost-utility analysis. Costs
are assessed from both a societal and health care perspective.
Discussion: This study is expected to provide insight in the effectiveness, including its cost-effectiveness, and delivery of
the SLIMMER diabetes prevention intervention conducted in Dutch primary health care. Results of this study provide
valuable information for primary health care professionals, researchers, and policy makers.
Trial registration: The SLIMMER study is registered with ClinicalTrials.gov (NCT02094911) since March 19, 2014.
Keywords: Type 2 diabetes mellitus, Prevention, Combined lifestyle intervention, Primary health care, Real-life setting,
Evaluation designBackground
Diabetes mellitus is one of the most challenging health
problems of the 21st century [1]. Randomised controlled
trials of lifestyle interventions have shown that a healthy
diet and increased physical activity reduce the incidence of
type 2 diabetes mellitus (T2DM) in impaired glucose tol-
erance patients [2-5]. This evidence calls for translation* Correspondence: geerke.duijzer@wur.nl
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in real-life settings to guide diabetes prevention policies.
As real-life settings are complex and limited in finances
and resources, it is a challenge to implement effective and
sustainable interventions [6-8]. Multiple reviews that in-
cluded studies conducted in several real-life settings,
showed significant reductions in weight and waist circum-
ference but inconclusive results for metabolic indicators of
diabetes risk, such as blood glucose or HbA1c [7-10].
A comprehensive evaluation approach is required, as
interventions in real-life settings are often complex andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Within this approach, the scope of evaluation research
needs to broaden from assessing only effectiveness to also
getting insight in the delivery of an intervention. This will
provide insight in the so-called ‘black box’, that is identify
aspects that explain what works, how, and why [11,12].
Therefore, studies need to include a process evaluation to
establish the validity of the hypothesised causal processes
for behaviour change and taxonomies can be used to de-
scribe behaviour change techniques used to modify these
processes [13].
To date no effective diabetes prevention programme has
been implemented in Dutch primary health care [14-17].
Therefore, the Study on Lifestyle intervention and Im-
paired glucose tolerance Maastricht (SLIM), revealing a
47% diabetes risk reduction [5], was translated into the
SLIMMER intervention (SLIM iMplementation Experience
Region Noord- en Oost-Gelderland). Translation of this
intervention was done in a joint decision making process
between SLIM intervention developers and local health
care professionals [18]. Pilot-testing of the adapted inter-
vention showed that implementation of the SLIMMER
intervention was feasible in a Dutch real-life setting and
that it was likely to achieve desired impact [19]. These re-
sults serve as input for the next step of broader implemen-
tation and evaluation of the intervention in a real-life
setting.
The aim of this article is to describe the evaluation de-
sign of the SLIMMER diabetes prevention intervention in
a Dutch real-life setting. This was done using a logic
model describing the hypothesised causal pathway, includ-
ing process indicators, behavioural determinants, and be-
havioural and health outcomes. The SLIMMER study will
address the following research questions:
1. Which effects can be measured regarding
behavioural determinants, eating and physical
activity behaviour, health, and quality of life?
(effect evaluation)
2. How is SLIMMER delivered and received in a
real-life setting? (process evaluation)




For this study, a logic model of change is composed to link
intervention activities, their mechanisms of change (i.e.
behavioural determinants), expected behaviours, and
intervention outcomes in a logical order. A logic model fa-
cilitates the understanding of intervention effectiveness
and provides insights for further improvements [20,21].
Figure 1 shows the logic model of change for the SLIM-
MER intervention. The overall aim of the intervention isto prevent or postpone T2DM and its consequences and to
increase quality of life. On the long-term, improvement in
fasting insulin is taken as the primary outcome, whereas
improvements in cardio-metabolic risk factors (e.g. glucose
tolerance, serum lipids, body fatness, and blood pressure)
are defined as secondary outcomes. Improvements in eating
behaviour and physical activity behaviour are intermediate
outcomes. Eating behaviour is measured as nutrient intake
and food intake. Physical activity behaviour is operationa-
lised as mode, frequency, duration, intensity, and activity
score. Improvements in intention, attitude, social influ-
ences, self-efficacy, motivation, action control, and skills are
formulated as initial outcomes. These outcomes are
achieved if sufficient outputs are delivered in terms of re-
cruitment, reach, dose delivered, dose received, acceptabil-
ity, implementation integrity, applicability, and context.
Study design
The SLIMMER study is a randomised, controlled interven-
tion study, carried out in the Netherlands by a consortium
of Wageningen University (WU, Wageningen) and the
Community Health Service Noord- en Oost-Gelderland
(GGD NOG, Apeldoorn). The total duration of the study is
1.5 years with an intervention period of 10 months. Re-
cruitment of participants took place from October 2011 to
September 2012. After baseline measurements, participants
are randomly allocated to the intervention or control
group, using block randomisation on the level of general
practitioners (GPs) and stratification for gender. Couples
are allocated to the same group to avoid contamination.
Randomisation was performed by an independent dietician
of the division of Human Nutrition (WU, Wageningen).
The SLIMMER study has been registered with Clinical-
Trials.gov (Identifier NCT02094911) since March 19, 2014.
The WU Medical Ethics Committee approved the study
protocol and all subjects gave their written informed con-
sent before the start of the study.
Setting
This study is carried out in Apeldoorn and Doetinchem,
two average, middle-sized, Dutch cities, located in the east-
ern part of the Netherlands. The SLIMMER intervention is
implemented in Dutch public health and primary health
care, involving GPs and their practice nurses, dieticians,
physiotherapists, and sports clubs. Within the study setting,
GPs are organised in a formal network to deliver coordi-
nated diabetes care. The majority of dieticians is employed
by a home care organisation, only few are self-employed.
No regional organisation or network for physiotherapists
exists. All GPs have natural referral lines with at least one
dietician and in most cases with one physiotherapy practice
in the neighbourhood. This existing structure is used for
implementation of the SLIMMER intervention. Further-
more, the project is coordinated by the community health
Inputs
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To promote a healthy 
lifestyle (healthy nutrition 
and increased physical 
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onset of type 2 diabetes 
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to quality of life and active 
participation in society.
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Figure 1 Logic model of change for the SLIMMER intervention.
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Sports clubs are organised in a municipal sports stimulation
organisation, which has an important role in the mainten-
ance programme.
Sample size calculation
The sample size calculation for this study is estimated
based on changes in fasting insulin, observed in SLIM
after one year [22]. In the SLIM study, mean difference in
fasting insulin between groups was 2.9 mU/l with a stand-
ard deviation of 5.3 mU/l [22]. Because SLIMMER is con-
ducted in a real-life setting instead of a controlled setting,
it is estimated to achieve 75% of this result, that is an ex-
pected difference in fasting insulin between intervention
and control group of 2.175 mU/l. Because we expect a lar-
ger SD in a real-life setting, we use 6 mU/l. To adjust for
clusters (i.e. general practices), an intra-cluster correlation
of 0.055 is used [23]. Based on results of SLIM [22] and
the SLIMMER pilot study [19], we expect a drop-out rate
of 10%. Assuming an alpha of 0.05, power of 80%, and
two-sided test, a sample size of 145 subjects per group is
required.
Study population
GPs and practice nurses have selected patients aged 40
through 70 years suffering from impaired fasting glucose(IFG: i.e. fasting plasma glucose concentration 6.1-
6.9 mmol/l [24]) in the past five years from their patient
registration database. Patients are recruited using either
laboratory glucose test or the Dutch Diabetes Risk Test
[25]. Patients are considered for participation if they still
suffer from IFG or if the test score indicates an elevated
or high risk of T2DM (i.e. a score of ≥7 points). Inclu-
sion and exclusion criteria (Table 1) are checked by GPs
using electronic medical records. GPs have invited eli-
gible patients to participate in the SLIMMER study. A
short non-response survey is conducted in case patients
are not willing to participate.
Lifestyle intervention programme
The SLIMMER intervention resembles the SLIM interven-
tion [5], which was based on the Finnish Diabetes Preven-
tion Study [4]. The SLIM intervention used a combination
of theories, such as Stages of Change model [26] and
Theory of Planned Behaviour [27], and tools, such as
motivational interviewing [28] and goal setting. SLIMMER
is a 10-month combined lifestyle intervention consisting of
a dietary and physical activity component, including case
management and a maintenance programme. The SLIM-
MER intervention conforms regular functioning and pro-
fessional performance of Dutch GPs, practice nurses,
dieticians, and physiotherapists. Minimal training and a
Table 1 Inclusion and exclusion criteria for the SLIMMER study
Inclusion criteria Age 40 through 70 years
Impaired fasting glucose (IFG; i.e. fasting plasma glucose concentration 6.1-6.9 mmol/l [24]) in the past 5 years
according to the patient registration database, OR risk score ≥7 points based on the Dutch Diabetes Risk Test [25]
Willing and able to participate in the study for at least 1.5 years
Able to speak and understand the Dutch language
Exclusion criteria Known diabetes mellitus
Any chronic illness that makes 1.5-years survival improbable, interferes with glucose tolerance, or makes participation
in a lifestyle intervention impossible
Any severe cardiovascular disease (including history of cardiac dysrhythmia), unless general practitioner gives agreement
Medication known to interfere with glucose tolerance (mainly systemic glucocorticoids and pituitary
gland/hypothalamus hormones)
Any mental or physical disability that will hinder participation in a lifestyle intervention
Severe psychiatric disease
Patients showing bad compliance in the past
Participation in another regular vigorous exercise and/or dietary programme, i.e.:
- Intensive physical activity programme: any physical activity programme offered by a physiotherapist
and/or patients sporting at least three times a week at own initiative
- Intensive dietary programme: patients who visited a dietician at least three times during the last year
Patients who participated in the SLIMMER pilot study
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MER kick-off training for health care professionals. In total,
25 general practices, 11 dieticians, nine physiotherapy
practices, and 15 sports clubs are participating in the
SLIMMER study. An overview of core tasks and compe-
tences of these professionals is given in Additional file 1.
Details of the lifestyle intervention programme are de-
scribed below.
Dietary intervention
The dietary intervention is consisting of tailored dietary
advice during individual consultations and one group ses-
sion and is aimed to adopt, step by step, a sustainable
healthy dietary pattern according to the Dutch dietary
guidelines [29]. Furthermore, it is aimed to help partici-
pants to achieve 5-10% weight loss. Dietary recommenda-
tions are based on Dutch dietary guidelines [29], focussed
on people at risk of developing diabetes. Dietary advice is
given by a dietician from primary health care, trained in
motivational interviewing [28] and using positive feedback.
The number of consultations is flexible, ranging from five
to eight (30–60 minutes per consultation; maximum of
4 hours per participant), and dependent on needs of par-
ticipants. If desired, spouses could join consultations. In
addition, the dietician organises one group session aimed
at sharing experiences, motivating each other, and discuss-
ing the topic of label reading. Subjects are encouraged to
drink less alcohol, quit smoking if necessary, increase daily
physical activity, and to participate in the physical activity
intervention. To stimulate self-management of participants,
goals for behaviour change are set each consultation,evaluated in the next consultation, and if necessary ad-
justed. Halfway and at the end of the intervention, behav-
iour change is more extensively evaluated by dieticians to
motivate participants, prevent drop-out, and discuss pro-
gression and goals.
Physical activity intervention
The physical activity intervention is consisting of a com-
bined aerobic and resistance exercise programme at the
physiotherapist’s practice and is aimed to obtain and main-
tain an active lifestyle, that is moderate-intensity physical
activity for at least 30 minutes per day on at least five days
a week. Physical activity recommendations are based on
Dutch guidelines for physical activity and type 2 diabetes
[30]. Participants have free access to group-based training
sessions and are stimulated to participate for at least one
hour per week (maximum of two hours per week). Train-
ing sessions are given by a physiotherapist from primary
health care and tailored to individual needs, desires, and
opportunities. In addition, physiotherapists give tailored
advice on how to increase physical activity in daily life (e.g.
bicycling, walking) and goals are set. After three, six and
ten months, behaviour change is monitored by physiother-
apists (e.g. weight, waist circumference, and body fat per-
centage) aimed to motivate participants, prevent drop-out,
and discuss progression and goals.
Case management
Practice nurses are appointed as case managers of the
intervention programme to enhance participant compli-
ance and the feasibility of the implementation. They
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the start of the intervention. Furthermore, they have the
overview of the programme and work together with die-
ticians and physiotherapists. Four weeks after the start
of the intervention and halfway the intervention, prac-
tice nurses contact dieticians, physiotherapists, and par-
ticipants of the intervention group to facilitate contact
among health care professionals, to detect and solve
problems, and to motivate and support participants.
Maintenance programme
A maintenance programme is added to the combined life-
style intervention to guide participants in the process of
maintaining lifestyle behaviour change in an independent
and sustainable manner. This maintenance programme in-
cludes 1) intermediate evaluations (e.g. measurement of
weight, waist circumference, and body fat percentage) by di-
eticians and physiotherapists to provide feedback and stimu-
late self-management; 2) sports clinics at local sports clubs
to introduce participants to different sports activities; 3) final
interviews with dieticians and physiotherapists at the end of
the intervention to give positive feedback, discuss behaviour
maintenance, and to set goals; 4) return visit with dieticians
and physiotherapists to motivate and support participants in
maintaining a healthy lifestyle; and 5) monitoring by practice
nurses (i.e. discuss and monitor behaviour change during
consultations at the general practice).
Control group
Subjects in the control group receive usual health care as
provided by GPs and practice nurses. Furthermore, they
receive a minimal intervention at the start of the study,
consisting of written information about beneficial effects
of a healthy diet and increased physical activity, whereas
no individual advice or programme is provided. No add-
itional appointments are scheduled, apart from visits for
follow-up measurements.
Outcomes
Clinical assessments are performed by trained research as-
sistants in research centres in Apeldoorn and Doetinchem.
Furthermore, process and economic data are collected.
Participants are measured at baseline (T0), after the inter-
vention (12 months, T1), and six months after ending the
intervention (18 months, T2). At each time point, partici-
pants are invited for two sessions on different days: one in
the morning and one in the afternoon. Additional file 2
gives an overview of indicators, methods, and time points
of the data collection.
Effect evaluation
Socio-demographic characteristics
Participants fill in questionnaires on socio-demographic
characteristics. Data on age, gender, education, ethnicbackground, marital status, job status, and smoking are
collected according to standards of the national surveil-
lance system for adults and the elderly in the Netherlands
[31]. These national standards are based on best available
scientific insights, experiences of local community health
services, and expert opinions. Family history of diabetes is
measured with a question from the Dutch Diabetes Risk
Test [25]. Data on disease history are collected based on
questions from the CoDAM study (Cohort study Diabetes
and Atherosclerosis Maastricht) [32]. Non-response data
(i.e. age, gender, reason for non-participation, perceived
health, and education) are collected during the recruit-
ment period by practice nurses.
Overall outcomes
Quality of life is assessed by the Short-Form Health Sur-
vey (SF-36), which proved to be a practical, reliable, and
valid tool for both general and chronic disease popula-
tions in the Netherlands [33,34].Long-term outcomes
A standard oral glucose tolerance test (OGTT; glucose
load 75 g) is performed by a trained nurse after at least
10 hours of fasting. Fasting and 2 h plasma glucose levels,
HbA1c, and serum lipids (cholesterol (total, HDL, LDL)
and triglycerides) are determined at SHO laboratory in
Velp, the Netherlands. For fasting and 2 h serum insulin,
all blood samples are analysed within one run after
18 months. An index for insulin resistance is calculated
from fasting plasma glucose and insulin concentration,
using the homeostasis model assessment (HOMA index)
[35]. Body mass index (BMI) is calculated as the ratio of
weight and height squared (kg/m2). Waist circumference
is obtained at the level midway between the lowest rib and
the iliacal crest. Hip circumference is measured as the
maximum circumference over the buttocks. Body fat per-
centage is measured by bio-impedance analysis (Tanita
BC-418). Physical fitness is measured by the six-minute
walk test [36], measuring the distance that participants
walk within six minutes, which is an indicator of physical
functional capacity. This is a simple, safe, and inexpensive
sub-maximal exercise test [37]. In addition to distance,
heart beat rate after six minutes and rating of perceived
exertion are obtained using the 6–20 category Borg scale
[38]. Blood pressure and heart beat rate at rest are mea-
sured using the Omron Digital Blood Pressure Monitor
HEM-907. Self-reported use of medication (name, fre-
quency, and duration of medication use) is determined
using a questionnaire [39]. Diabetes incidence is based on
data of self-reported medication use which are verified by
GPs. Cardiovascular events are based on self-reported data
measured by a questionnaire [32]. Procedures of measure-
ments are described in protocols.
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Eating behaviour is operationalised as nutrient intake and
food intake. Nutrient intake is assessed by a validated Food
Frequency Questionnaire (FFQ) [40,41]. FFQs are checked
by trained research assistants. Average daily nutrient in-
takes are calculated by multiplying frequency of consump-
tion by portion size and nutrient content per gram using
the Dutch food composition table of 2006 [42]. Six food in-
take behaviours are formulated based on Dutch food-based
dietary guidelines [43] and common dietician practices in
the SLIMMER pilot study [19]: 1) eating 200 grams of fruit
every day; 2) eating 200 grams of vegetables every day; 3)
eating more whole grain bread; 4) eating less unhealthy
snacks; 5) replacing fat bread spreads with lean bread
spreads; and 6) drinking less soft drinks. These food intake
behaviours are measured by an FFQ [40,41]. Physical activ-
ity behaviour is measured using the Short Questionnaire to
Assess Health-enhancing physical activity (SQUASH),
including questions on commuting activities, leisure
time activities, household activities, and activities at
work [44]. Physical activity behaviour is operationalised
as mode, frequency, duration, intensity, and activity
scores (i.e. total minutes of activity * intensity score). The
SQUASH is a short, simple, reliable, and valid measure for
categorising adults to their level of physical activity
[44,45]. In addition, a question on sedentary behaviour is
added, based on the Activity Questionnaire for Adults and
Adolescents (AQuAA) [46].
Initial outcomes
A questionnaire is developed to measure behavioural de-
terminants, as no validated questionnaires are available to
measure determinants of specific nutrition and physical
activity behaviours in adults at high risk of T2DM.
To inform the development of the questionnaire, the
Theoretical Domains Framework [47,48] is used in which
behaviour change techniques, used in the SLIMMER
intervention, are linked to behavioural determinants. The
final questionnaire contains items on intention, attitude,
social influences, self-efficacy, motivation, action control,
and skills. Items are based on questions and scales de-
scribed by Fishbein and Azjen [49], Lakerveld et al. [50],
and Helmink et al. [51].
Process evaluation
To assess how the SLIMMER intervention is delivered and
received in a real-life setting, data from both participants
and health care professionals are collected. A process evalu-
ation plan is designed based on strategies of Steckler and
Linnan [52], Saunders et al. [53], Nutbeam [54], and Wang
et al. [55]. Process measures include recruitment, reach,
dose delivered, dose received, acceptability, implementation
integrity, applicability, and context. These process measures
are assessed using the project logbook, non-responsesurveys, participant questionnaires, registration forms,
attendance lists, and semi-structured interviews with
health care professionals.
Economic evaluation
Costs and effects of the SLIMMER intervention are
compared with those of the usual care. Economic evalu-
ation is performed from a societal perspective, taking
all costs and benefits into account. In addition, a health
care perspective is considered, in which only direct
medical costs are taken into account. As in the effect
evaluation, a time horizon of 1.5 years is used. Both a
cost-effectiveness analysis (CEA) and a cost-utility analysis
(CUA) are performed. The CEA presents clinical out-
comes in terms of reduction of fasting insulin. The CUA
presents outcomes in terms of quality-adjusted life years
(QALYs), determined by the SF-6D health state classifi-
cation, a preference-based single index derived from the
SF-36 [56,57]. Intervention costs, health care costs,
medication costs, patient costs, as well as productivity
losses are assessed. In order to estimate intervention
costs, time spent by different types of staff involved
(practice nurses, dieticians, physiotherapists, providers
of sports clinics, and project coordinator) and materials
are identified by means of the project logbook,
attendance lists, and registration forms. Volumes of
health care use, medication use, absence from work, and
other expenses are identified by means of participant
questionnaires and registration forms. Costs associated
with resources use are valued following Dutch guidelines
for costing research within health economic evaluations
[58,59]. If no standard cost prices are available, cost esti-
mates from literature are used. All costs are expressed as
year 2012 Euros. Where necessary, costs are indexed to
the baseline year, as suggested in the Dutch manual
[58,59]. Costs and effects in the second year are dis-
counted at Dutch standard discounting rates of 4%
(costs) and 1.5% (effects).
Data analysis
Quantitative data analyses are performed following the
intention-to-treat procedure. If necessary, data are trans-
formed and analyses are adjusted for baseline measure-
ments and possible differences between groups at baseline.
To adjust for clustering on GP level, multilevel analyses are
performed. To determine differences in effects between
groups, multivariate analysis techniques are performed.
Two-sided P values are calculated and a significance level
of 0.05 is applied.
Qualitative data analyses are performed using an induct-
ive approach [60]. Interviews with health care professionals
are audiotaped and transcribed verbatim. All transcripts are
read by two researchers individually to identify frequently
emerging themes. These themes are used to create a coding
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pects of how the intervention is delivered and received.
Differences in costs and effects between intervention
and control group are expressed as incremental cost-
effectiveness ratios (ICERs). ICERs are plotted on a
cost-effectiveness plane, a four quadrant diagram with a
horizontal axis representing effect differences between
the intervention and control group and the vertical axis
representing costs differences between groups. In addition,
a cost-effectiveness acceptability curve is constructed,
which shows the probability that the SLIMMER interven-
tion is cost-effective for a range of cost-effectiveness
thresholds. Sensitivity analyses are conducted to assess ro-
bustness of results.
Discussion
Implementation of diabetes prevention interventions in
real-life settings requires a comprehensive evaluation ap-
proach. The design of the SLIMMER intervention de-
scribed in this paper offers an appropriate evaluation
strategy. Firstly, the logic model will facilitate understand-
ing of the intervention effectiveness by assessing outcomes
at several levels. Furthermore, the randomised design was
adapted to be suitable for application in primary health
care practice by incorporating block randomisation on GP
level. Secondly, more attention is given to the process of
intervention delivery, which is important for real-life, and
thus less standardised, interventions. Thirdly, the eco-
nomic evaluation will provide policy makers with valuable
information on costs and benefits of an intervention.
In conclusion, this study is expected to provide insight
in the effectiveness, including its cost-effectiveness, and
delivery of the SLIMMER diabetes prevention intervention
conducted in Dutch primary health care. Furthermore, it
is expected that this study will facilitate our understanding
of intervention components and characteristics that are
associated with effectiveness. Results of this study provide
valuable information for primary health care professionals,
researchers, and policy makers.
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primary health care professionals involved in the SLIMMER
intervention.
Additional file 2: Overview of indicators, methods, and time points
of data collection.
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